TCG Crossover Management, LLC Diversified Active

Location: Palo Alto, CA

CIK: 0001839948 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 14, 2023

Total Value: $567M (100.0% shares, 0.0% debt)

Holdings (21)

— IVERIC BIO INC 19.4%
Value $110M Shares 5,141,118 Share Price $21.41 Est. Cost/Share $17.57 Unrealized @ Report Date —
MDGL MADRIGAL PHARMACEUTICALS INC 14.8%
Value $83.61M Shares 288,054 Share Price $290.25 * Est. Cost/Share $94.85 Unrealized @ Report Date +3.1%
COGT COGENT BIOSCIENCES INC 7.4%
Value $41.97M Shares 3,631,042 Share Price $11.56 * Est. Cost/Share $8.48 Unrealized @ Report Date +46.1%
— CYMABAY THERAPEUTICS INC 6.5%
Value $37.03M Shares 5,905,400 Share Price $6.27 Est. Cost/Share $3.38 Unrealized @ Report Date —
GERN GERON CORP 6.5%
Value $36.75M Shares 15,187,073 Share Price $2.42 * Est. Cost/Share $1.36 Unrealized @ Report Date +65.3%
SLN SILENCE THERAPEUTICS PLC 5.7%
Value $32.1M Shares 2,104,875 Share Price $15.25 Est. Cost/Share $10.03 Unrealized @ Report Date —
— AEROVATE THERAPEUTICS INC 5.6%
Value $31.68M Shares 1,081,274 Share Price $29.30 Est. Cost/Share $14.29 Unrealized @ Report Date —
VRDN VIRIDIAN THERAPEUTICS, INC 5.1%
Value $28.73M Shares 983,610 Share Price $29.21 * Est. Cost/Share $18.63 Unrealized @ Report Date +23.7%
VTYX VENTYX BIOSCIENCES, INC 4.6%
Value $25.81M Shares 787,231 Share Price $32.79 * Est. Cost/Share $29.62 Unrealized @ Report Date 0.0%
KALV KALVISTA PHARMACEUTICALS, INC 4.1%
Value $22.95M Shares 3,395,495 Share Price $6.76 * Est. Cost/Share $5.36 Unrealized @ Report Date 0.0%
— VECTIVBIO HOLDING AG 3.6%
Value $20.22M Shares 2,333,300 Share Price $8.67 Est. Cost/Share $8.66 Unrealized @ Report Date —
ACRS ACLARIS THERAPEUTICS INC 3.2%
Value $18.03M Shares 1,144,939 Share Price $15.75 * Est. Cost/Share $15.07 Unrealized @ Report Date +6.8%
KURA KURA ONCOLOGY INC 3.1%
Value $17.67M Shares 1,423,642 Share Price $12.41 * Est. Cost/Share $14.54 Unrealized @ Report Date -0.1%
IMVT IMMUNOVANT, INC 2.7%
Value $15.17M Shares 854,853 Share Price $17.75 * Est. Cost/Share $12.59 Unrealized @ Report Date 0.0%
TYRA TYRA BIOSCIENCES INC 2.7%
Value $15.12M Shares 1,989,103 Share Price $7.60 * Est. Cost/Share $12.71 Unrealized @ Report Date -44.3%
MLTX MOONLAKE IMMUNOTHERAPEUTICS 1.9%
Value $10.5M Shares 1,000,000 Share Price $10.50 * Est. Cost/Share $6.29 Unrealized @ Report Date +41.5%
TRDA ENTRADA THERAPEUTICS INC 1.4%
Value $7.909M Shares 584,955 Share Price $13.52 Est. Cost/Share $17.12 Unrealized @ Report Date —
— MERUS BV 0.8%
Value $4.641M Shares 300,000 Share Price $15.47 Est. Cost/Share $30.46 Unrealized @ Report Date —
CABA CABALETTA BIO, INC 0.8%
Value $4.503M Shares 486,795 Share Price $9.25 * Est. Cost/Share $3.64 Unrealized @ Report Date 0.0%
— ALPINE IMMUNE SCIENCES INC 0.3%
Value $1.86M Shares 253,069 Share Price $7.35 Est. Cost/Share $13.85 Unrealized @ Report Date —
— ELEVATION ONCOLOGY INC 0.0%
Value $274K Shares 288,390 Share Price $0.95 Est. Cost/Share $6.02 Unrealized @ Report Date —